Mayne Pharma (MYX AU)

Analysis

Health Care • Australia

Mayne Pharma Group Ltd. develops and manufactures oral pharmaceuticals. The Company produces branded generics, specialty generics, and active pharmaceutical ingredients.

Refresh

Focused

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00